Liminal BioSciences Inc.

LMNL · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$37,144$108,490$45,075$61,285
Short-Term Investments$0$0$0$0
Receivables$1,177$1,068$3,903$13,300
Inventory$0$0$9,377$7,532
Other Curr. Assets$2,997$5,071$14,664$12,733
Total Curr. Assets$41,318$114,629$73,019$94,850
Property Plant & Equip (Net)$5,490$7,092$27,348$54,725
Goodwill$0$0$0$0
Intangibles$3,240$3,516$15,492$13,846
Long-Term Investments$0$0$0$1,001
Tax Assets$168$454$572$507
Other NC Assets$243$362$1,353$169
Total NC Assets$9,141$11,424$44,765$70,248
Other Assets$0$0$0$0
Total Assets$50,459$126,053$117,784$165,098
Liabilities
Payables$3,403$5,762$9,153$10,496
Short-Term Debt$735$7,194$6,946$8,455
Tax Payable$0$113$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,965$5,425$7,682$12,312
Total Curr. Liab.$10,103$18,494$23,781$31,263
LT Debt$752$53,588$67,038$38,616
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,396$20,090$11,953$285
Total NC Liab.$4,148$73,678$78,991$38,901
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$14,251$92,172$102,772$70,164
Equity
Pref Stock$0$0$0$0
Common Stock$979,849$979,849$977,261$932,951
Retained Earnings-$1,082,301-$1,074,167-$1,087,049-$967,051
AOCI-$3,169-$3,010-$2,846-$3,099
Other Equity$141,829$139,965$135,733$139,388
Total Equity$36,208$42,637$23,099$102,189
Supplemental Information
Minority Interest$0-$8,756-$8,087-$7,255
Total Liab. & Tot. Equity$50,459$126,053$117,784$165,098
Net Debt-$35,657-$47,708$28,909-$14,214